Nexalin Technology (NXL) Research & Development (2024 - 2026)
Nexalin Technology (NXL) posted quarterly Research & Development of $346382.0 for Q1 2026, down 14.74% year-over-year from $406288.0 in Q1 2025, and up 53.99% quarter-over-quarter from $224940.0 in Q4 2025.
Nexalin Technology (NXL) Research & Development (2024 - 2026) Analysis & Trends
Nexalin Technology's Research & Development history runs 3 years deep, the most recent figure standing at $346382.0 for Q1 2026.
- In Q1 2026, Research & Development fell 14.74% year-over-year to $346382.0; the TTM figure through Mar 2026 stood at $1.0 million (down 31.37% YoY), while the FY2025 annual figure was $1.1 million, down 9.02% from the prior year.
- Research & Development for Q1 2026 stood at $346382.0, up from $224940.0 in the prior quarter.
- The five-year high for Research & Development was $737242.0 in Q4 2024, with the low at $105668.0 in Q1 2024.
- The 3-year median for Research & Development is $225774.0 (2025), against an average of $291198.8.
- Peak annual rise in Research & Development reached 284.49% in 2025, while the deepest fall reached 69.49% in 2025.
- Nexalin Technology's Research & Development stood at $737242.0 in 2024, then plunged by 69.49% to $224940.0 in 2025, then surged by 53.99% to $346382.0 in 2026.
- Business Quant data shows NXL's Research & Development at $346382.0 in Q1 2026, $224940.0 in Q4 2025, and $226520.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.50 Bn | 194.89 Bn | 7.27 Bn | 892.00 Mn |
| 2 | Stryker | 130.00 Bn | 126.52 Bn | 4.50 Bn | 434.00 Mn |
| 3 | Medtronic | 120.36 Bn | 111.14 Bn | 6.41 Bn | 671.00 Mn |
| 4 | Boston Scientific | 74.19 Bn | 73.65 Bn | 3.85 Bn | 554.00 Mn |
| 5 | Edwards Lifesciences | 52.73 Bn | 48.48 Bn | 1.35 Bn | 278.90 Mn |
| 6 | Dexcom | 34.64 Bn | 32.70 Bn | 830.00 Mn | 153.00 Mn |
| 7 | GE HealthCare Technologies | 34.13 Bn | 32.02 Bn | 2.18 Bn | 323.00 Mn |
| 8 | Koninklijke Philips | 26.52 Bn | 23.20 Bn | 4.55 Bn | -562.58 Mn |
| 9 | Steris | 23.23 Bn | 22.75 Bn | 684.20 Mn | 28.60 Mn |
| 10 | Nexalin Technology | 7.11 Mn | 6.11 Mn | 8,897.00 | 564,480.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 564,480.00 |
| Mar 31, 2026 | 346,382.00 |
| Dec 31, 2025 | 224,940.00 |
| Sep 30, 2025 | 226,520.00 |
| Jun 30, 2025 | 225,774.00 |
| Mar 31, 2025 | 406,288.00 |
| Dec 31, 2024 | 737,242.00 |
| Sep 30, 2024 | 178,565.00 |
| Jun 30, 2024 | 169,410.00 |
| Mar 31, 2024 | 105,668.00 |